Fundraising FoxPersuasive
1 known investors
Find your way into Persuasive
Persuasive develops a platform technology for high-throughput analysis of extracellular vesicles (EVs) and is building a blood-based diagnostic test using an EV protein biomarker signature to identify chronic coronary syndrome in primary-care patients presenting with chest pain. The company, spun out with UMC Utrecht researchers, targets early diagnosis of stable angina to reduce unnecessary hospital referrals.
Founders & leadership
DE
Dr. Egbert Smit, MBACEO
Investors · 1
NLClisted by NLCAmsterdam
How we know: NLC's portfolio page · Not right? Tell us
Frequently asked questions
- What does Persuasive do?
- Persuasive develops a platform technology for high-throughput analysis of extracellular vesicles (EVs) and is building a blood-based diagnostic test using an EV protein biomarker signature to identify chronic coronary syndrome in primary-care patients presenting with chest pain. The company, spun out with UMC Utrecht researchers, targets early diagnosis of stable angina to reduce unnecessary hospital referrals.
- Who are Persuasive's investors?
- Persuasive's investors include NLC.